Carson City resident in her 70s dies from COVID-19


  • Discuss Comment, Blog about
  • Print Friendly and PDF

Carson City Health and Human Services (CCHHS) is reporting am additional death due to COVID-10 in the Quad-County Region. The individual was a female Carson City resident in her 70’s.

 

CCHHS is also reporting 10 new cases and 45 additional recoveries of COVID-19 in the Quad-County Region. This brings the total number of cases to 11,263, with 9,131 recoveries and 208 deaths; 1,924 cases remain active.

 


Total Cases 

Active Cases

Recoveries

Deaths

*Population

Carson City

5,908

1,006

4,787

115

56,546

Douglas County

2,527

450

2,044

33

49,695

Lyon County

2,750

463

2,230

57

57,987

Storey County

78

5

70

3

4,465

Quad-County

11,263

1,924

9,131

208

168,693

 

*Population information taken from the Nevada Health Response Dashboard found at https://nvhealthresponse.nv.gov/

 

  • Total Number of Doses Received: 21,350 (+4,100 from 2/22)
    • 1st Doses: 13,975 (+3,100 from 2/22)
    • 2nd Doses: 7,375 (+1,000 from 2/22)
  • 1st Doses: 11,509 (+1,993 from 2/22)
  • 2nd Doses: 7,425 (+2,389 from 2/22)

 

Drive-Thru COVID-19 Testing for Quad-County Residents 

 

Testing is for Quad-County (Carson City, Douglas, Lyon, and Storey County) residents ONLY, all others will be turned away. Testing is free of charge, no appointments or reservations. To view all upcoming events visit  https://gethealthycarsoncity.org/events/

 

Date

Time

Location

3/03/2021

10 a.m. to 11:30 a.m.

New Yerington City Hall

14 East Goldfield Ave, Yerington 

 

For those who are experiencing symptoms of COVID-19 or have questions related to testing, call the Quad-County COVID-19 Hotline Monday through Friday, 8:30 am to 4:30 pm. Spanish speakers are available. The phone number is (775) 434-1988.

 

For COVID-19 vaccine questions, eligibility questions, or for assistance scheduling a vaccination appointment, call the Nevada COVID-19 Vaccine Call Center at 1(800) 401-0946.


Comments

Use the comment form below to begin a discussion about this content.

Sign in to comment